Your browser doesn't support javascript.
loading
Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes.
Meier, Juris J; Granhall, Charlotte; Hoevelmann, Ulrike; Navarria, Andrea; Plum-Moerschel, Leona; Ramesh, Chethana; Tannapfel, Andrea; Kapitza, Christoph.
Afiliação
  • Meier JJ; Diabetes Division, Department of Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Granhall C; Translational Medicine, Novo Nordisk A/S, Søborg, Denmark.
  • Hoevelmann U; Profil, Neuss, Germany.
  • Navarria A; Translational Medicine, Novo Nordisk A/S, Søborg, Denmark.
  • Plum-Moerschel L; Profil, Mainz, Germany.
  • Ramesh C; Novo Nordisk Service Centre India Private Ltd, Novo Nordisk, Bangalore, India.
  • Tannapfel A; Diabetes Division, Department of Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Kapitza C; Profil, Neuss, Germany.
Diabetes Obes Metab ; 24(4): 684-692, 2022 04.
Article em En | MEDLINE | ID: mdl-34957654
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Gastroenteropatias Limite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Gastroenteropatias Limite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article